Aster DM Healthcare's Board has convened and approved the unaudited financial results for the quarter ended December 31, 2024, alongside the Limited Review Report.

The company reported an interim dividend of ₹4 (₹4 crore) per equity share, with a record date set for February 10, 2025, to determine shareholder entitlement.

This update signals a commitment to returning value to shareholders and may enhance investor sentiment due to the dividend declaration, reflecting the firm's financial strength and operational stability.

However, the recent losses in both standalone and consolidated results could present potential risks to future profitability.